Biosimilar naming convention undecided for now


The TGA says it is continuing to discuss the adoption of a naming convention for biosimilars with other overseas regulators. The revelation comes following the release of a communiqué from the August meeting of the Biosimilar Awareness Initiative Reference Group, which was set up to “give guidance on the activities of the Biosimilar Awareness Initiative ...


Already a member? Login to keep reading


OR
© 2017 the limbic